Sarah Diver

6.1k total citations · 1 hit paper
26 papers, 587 citations indexed

About

Sarah Diver is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Sarah Diver has authored 26 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 5 papers in Immunology. Recurrent topics in Sarah Diver's work include Asthma and respiratory diseases (15 papers), Respiratory and Cough-Related Research (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Sarah Diver is often cited by papers focused on Asthma and respiratory diseases (15 papers), Respiratory and Cough-Related Research (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Sarah Diver collaborates with scholars based in United Kingdom, United States and Singapore. Sarah Diver's co-authors include Christopher E. Brightling, Claire Emson, Gene Colice, Ayman Megally, Jane R. Parnes, Latifa Khalfaoui, Andrew Menzies‐Gow, Sally E. Wenzel, Néstor A. Molfino and Michael E. Wechsler and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Thorax.

In The Last Decade

Sarah Diver

25 papers receiving 579 citations

Hit Papers

Effect of tezepelumab on airway inflammatory cells, remod... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
    2021 225 citations Sarah Diver, Latifa Khalfaoui et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Diver United Kingdom 9 437 322 138 111 91 26 587
Nikolina Icitovic United States 8 393 0.9× 275 0.9× 131 0.9× 85 0.8× 44 0.5× 12 506
Jean‐Pierre Llanos United States 14 476 1.1× 336 1.0× 114 0.8× 152 1.4× 42 0.5× 41 565
Anna Rigazio United Kingdom 5 614 1.4× 513 1.6× 92 0.7× 74 0.7× 57 0.6× 6 678
Mary Buatti Small United States 6 495 1.1× 396 1.2× 78 0.6× 70 0.6× 50 0.5× 7 546
Steen Nepper-Christensen Denmark 12 332 0.8× 196 0.6× 29 0.2× 209 1.9× 33 0.4× 16 480
Ismail Kasujee Spain 8 207 0.5× 122 0.4× 96 0.7× 78 0.7× 20 0.2× 30 336
Erkki Vesterinen Finland 8 369 0.8× 162 0.5× 79 0.6× 230 2.1× 14 0.2× 8 552
Margaret McCormick Australia 4 249 0.6× 134 0.4× 186 1.3× 23 0.2× 90 1.0× 14 359
Johannes Martin Schmid Denmark 13 325 0.7× 128 0.4× 67 0.5× 300 2.7× 13 0.1× 43 504
Cris Roxas United Kingdom 12 576 1.3× 483 1.5× 124 0.9× 156 1.4× 34 0.4× 38 650

Countries citing papers authored by Sarah Diver

Since Specialization
Citations

This map shows the geographic impact of Sarah Diver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Diver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Diver more than expected).

Fields of papers citing papers by Sarah Diver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Diver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Diver. The network helps show where Sarah Diver may publish in the future.

Co-authorship network of co-authors of Sarah Diver

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Diver. A scholar is included among the top collaborators of Sarah Diver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Diver. Sarah Diver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDowell, P. Jane, Adnan Azim, John Busby, et al.. (2025). Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma. Journal of Allergy and Clinical Immunology. 156(4). 911–922. 3 indexed citations
2.
Diver, Sarah, Fiona A. Symon, Jack Satchwell, et al.. (2025). Under the weather: an epidemic thunderstorm asthma event in Leicester, June 2023. BMJ Open Respiratory Research. 12(1). e002588–e002588. 1 indexed citations
3.
Howell, Imran, Freda Yang, Jennifer Cane, et al.. (2024). Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma. Journal of Allergy and Clinical Immunology. 154(5). 1146–1158. 2 indexed citations
4.
Nordenmark, Lars H., Åsa Hellqvist, Claire Emson, et al.. (2023). Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma. NEJM Evidence. 2(10). EVIDoa2300135–EVIDoa2300135. 53 indexed citations
5.
Diver, Sarah, Christopher E. Brightling, & Neil Greening. (2022). Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America. 42(3). 671–690. 2 indexed citations
6.
Yang, Freda, John Busby, Liam G. Heaney, et al.. (2022). Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma—A Randomized, Placebo-Controlled Crossover Trial (MAPLE). The Journal of Allergy and Clinical Immunology In Practice. 10(11). 2925–2934.e12. 8 indexed citations
7.
Diver, Sarah, Sriram Sridhar, Latifa Khalfaoui, et al.. (2022). Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial. Journal of Allergy and Clinical Immunology. 150(4). 830–840. 11 indexed citations
8.
Winslow, Sofia, Lina Odqvist, Sarah Diver, et al.. (2021). Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation andHaemophilusinfection in COPD. European Respiratory Journal. 58(4). 2003312–2003312. 42 indexed citations
9.
Diver, Sarah, et al.. (2021). The value of healthcare worker support strategies to enhance wellbeing and optimise patient care. Future Healthcare Journal. 8(1). e60–e66. 8 indexed citations
10.
Diver, Sarah, Latifa Khalfaoui, Claire Emson, et al.. (2021). Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine. 9(11). 1299–1312. 225 indexed citations breakdown →
11.
12.
13.
Diver, Sarah, Richard Russell, & Christopher E. Brightling. (2019). Cough and Eosinophilia. The Journal of Allergy and Clinical Immunology In Practice. 7(6). 1740–1747. 23 indexed citations
14.
15.
Ghebre, Michael A., Sarah Diver, Dhananjay Desai, et al.. (2018). Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles. Journal of Allergy and Clinical Immunology. 141(6). 2027–2036.e12. 114 indexed citations
16.
Diver, Sarah, Richard Russell, & Christopher E. Brightling. (2018). New and emerging drug treatments for severe asthma. Clinical & Experimental Allergy. 48(3). 241–252. 23 indexed citations
17.
Diver, Sarah, et al.. (2017). Safety of airway clearance techniques, sputum induction and bronchoscopy in severe asthma. PA648–PA648. 1 indexed citations
18.
Ryan, D, Robert Niven, Hassan Burhan, et al.. (2016). S3 The uk’s largest severe asthma multidisciplinary team meeting; experience from the first 18 months. Thorax. 71(Suppl 3). A5.1–A5.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolina Icitovic Breakdown of academic impact, for papers by Jean‐Pierre Llanos Breakdown of academic impact, for papers by Anna Rigazio Breakdown of academic impact, for papers by Mary Buatti Small Breakdown of academic impact, for papers by Steen Nepper-Christensen Breakdown of academic impact, for papers by Ismail Kasujee Breakdown of academic impact, for papers by Erkki Vesterinen Breakdown of academic impact, for papers by Margaret McCormick Breakdown of academic impact, for papers by Johannes Martin Schmid Breakdown of academic impact, for papers by Cris Roxas
Rankless by CCL
2026